R-CHOEP-14 improves overall survival in young high-risk patients with diffuse large B-cell lymphoma compared with R-CHOP-14. A population-based investigation from the Danish Lymphoma Group. [electronic resource]
Producer: 20120411Description: 147-153 p. digitalISSN:- 1569-8041
- Adult
- Aged
- Antibodies, Monoclonal, Murine-Derived -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cyclophosphamide -- administration & dosage
- Denmark
- Disease-Free Survival
- Doxorubicin -- administration & dosage
- Etoposide -- administration & dosage
- Female
- Humans
- Kaplan-Meier Estimate
- Lymphoma, Large B-Cell, Diffuse -- drug therapy
- Male
- Middle Aged
- Prednisone -- administration & dosage
- Proportional Hazards Models
- Registries
- Retrospective Studies
- Risk Factors
- Rituximab
- Treatment Outcome
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.